Early Living Donnor Kidney Transplantation-The Best Therapeutic Option For Developing Countries.

被引：0
|
作者：
Arze, R. [1 ]
Arze Aimaretti, L. [1 ]
机构：
[1] Ctr Med Quirurg Boliviano Belga, Cochabamba, Bolivia
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C1625
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [41] Prophylactic Effect of Mycophenolate Mofetil on Early Outcomes of Living Donor Kidney Transplantation
    Samadzadeh, Bahram
    Alemi, Mohsen
    Heidarnejadiyan, Jafar
    Torkamanasadi, Fatemeh
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2012, 6 (01) : 63 - 68
  • [42] Early Living-Donor Kidney Transplantation: A Review of the Associated Survival Benefit
    Liem, Ylian S.
    Weimar, Willem
    TRANSPLANTATION, 2009, 87 (03) : 317 - 318
  • [43] Mechanisms of dehydration early after kidney transplantation from living donors.
    Morooka, Kanako
    Miura, Masayoshi
    Harada, Hiroshi
    Seki, Toshimori
    Ishikawa, Syuuhei
    Higashiyama, Hiroshi
    Togashi, Masaki
    Hirano, Tetsuo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 461 - 461
  • [44] Infliximab as Therapeutic Option in Steroid-Refractory Ulcerative Colitis after Kidney Transplantation: Case Report
    Temme, J.
    Koziolek, M.
    Bramlage, C.
    Schaefer, I. M.
    Fuezesi, L.
    Ramadori, G.
    Mueller, G. A.
    Schwoerer, H.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3880 - 3882
  • [45] THERAPEUTIC CHOICES IN PATIENTS WITH PHI (+) CHRONIC MYELOGENOUS LEUKEMIA LIVING IN DEVELOPING COUNTRIES IN THE TYROSINE KINASE INHIBITORS (TKI) ERA: STEM CELL TRANSPLANTATION OR TKI?
    Ruiz-Arguelles, G. J.
    Tarin-Arzaga, L. C.
    Gonzalez-Carrillo, M. L.
    Gutierrez-Riveroll, K., I
    Rangel-Malo, R.
    Gutierrez-Aguirre, C. H.
    Cantu-Rodriguez, O. G.
    Gomez-Almaguer, D.
    Giralt, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 59 - 59
  • [46] Socioeconomic, demographic and policy comparisons of living and deceased kidney transplantation rates across 53 countries
    Bendorf, Aric
    Pussell, Bruce A.
    Kelly, Patrick J.
    Kerridge, Ian H.
    NEPHROLOGY, 2013, 18 (09) : 633 - 640
  • [47] Early Monitoring and Subsequent Gain of Tacrolimus Time-In-Therapeutic Range May Improve Clinical Outcomes After Living Kidney Transplantation
    Yin, Saifu
    Huang, Zhongli
    Wang, Zhiling
    Fan, Yu
    Wang, Xianding
    Song, Turun
    Lin, Tao
    THERAPEUTIC DRUG MONITORING, 2021, 43 (06) : 728 - 735
  • [48] Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience
    Ready, Andrew R.
    Nath, Jay
    Milford, David V.
    Adu, Dwomoa
    Jewitt-Harris, Jennie
    KIDNEY INTERNATIONAL, 2016, 90 (05) : 916 - 920
  • [49] Informing patients of the option for kidney transplantation at start of ESRD and access to the waiting list or a living donor transplant.
    Leichtman, A. B.
    Ashby, V. B.
    Mahadevan, S.
    Fan, P.-Y.
    Young, C. J.
    Fant, G. V.
    Wolte, R. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 564 - 564
  • [50] Kidney transplantation as a therapeutic option for end-stage renal disease long after heart transplantation: Should we all do it?
    Perrault, Louis P.
    Carrier, Michel.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : 378 - 379
12345